Cargando…
Drug Repositioning Screen on a New Primary Cell Line Identifies Potent Therapeutics for Glioblastoma
Glioblastoma is a malignant brain cancer with limited treatment options and high mortality rate. While established glioblastoma cell line models provide valuable information, they ultimately lose most primary characteristics of tumors under long-term serum culture conditions. Therefore, established...
Autores principales: | Senbabaoglu, Filiz, Aksu, Ali Cenk, Cingoz, Ahmet, Seker-Polat, Fidan, Borklu-Yucel, Esra, Solaroglu, İhsan, Bagci-Onder, Tugba |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7773901/ https://www.ncbi.nlm.nih.gov/pubmed/33390879 http://dx.doi.org/10.3389/fnins.2020.578316 |
Ejemplares similares
-
Tumor Cell Infiltration into the Brain in Glioblastoma: From Mechanisms to Clinical Perspectives
por: Seker-Polat, Fidan, et al.
Publicado: (2022) -
The pro-apoptotic Bcl-2 family member Harakiri (HRK) induces cell death in glioblastoma multiforme
por: Kaya-Aksoy, Ezgi, et al.
Publicado: (2019) -
DDRE-03. IDH1-MUTANT GBM CELLS ARE HIGHLY SENSITIVE TO COMBINATION OF KDM6A/B AND HDAC INHIBITORS
por: Kayabölen, Alişan, et al.
Publicado: (2021) -
Identification of SERPINE1 as a Regulator of Glioblastoma Cell Dispersal with Transcriptome Profiling
por: Seker, Fidan, et al.
Publicado: (2019) -
Epigenetic-focused CRISPR/Cas9 screen identifies (absent, small, or homeotic)2-like protein (ASH2L) as a regulator of glioblastoma cell survival
por: Ozyerli-Goknar, Ezgi, et al.
Publicado: (2023)